ArticleBMC rheumatology2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.
Katie Bechman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it